81 FR 96168 - Qualification of Drivers; Exemption Applications; Diabetes Mellitus
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration Federal Register Volume 81, Issue 250 (December 29, 2016)
Federal Motor Carrier Safety Administration
Federal Register Volume 81, Issue 250 (December 29, 2016)
| Page Range | 96168-96174 | |
| FR Document | 2016-31546 |
[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)] [Notices] [Pages 96168-96174] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-31546] ----------------------------------------------------------------------- DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA-2016-0381] Qualification of Drivers; Exemption Applications; Diabetes Mellitus AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation. ACTION: Notice of applications for exemptions; request for comments. ----------------------------------------------------------------------- SUMMARY: FMCSA announces receipt of applications from 41 individuals for exemption from the prohibition against persons with insulin-treated diabetes mellitus (ITDM) operating commercial motor vehicles (CMVs) in interstate commerce. If granted, the exemptions would enable these individuals with ITDM to operate CMVs in interstate commerce. DATES: Comments must be received on or before January 30, 2017. ADDRESSES: You may submit comments bearing the Federal Docket Management System (FDMS) Docket No. FMCSA-2016-0381 using any of the following methods:Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments. Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001. Hand Delivery: West Building Ground Floor, Room W12-140, 1200 [[Page 96169]] New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal Holidays. Fax: 1-202-493-2251. Instructions: Each submission must include the Agency name and the docket numbers for this notice. Note that all comments received will be posted without change to http://www.regulations.gov, including any personal information provided. Please see the Privacy Act heading below for further information. Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., e.t., Monday through Friday, except Federal holidays. The Federal Docket Management System (FDMS) is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self- addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line. Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL-14 FDMS), which can be reviewed at www.dot.gov/privacy. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. SUPPLEMENTARY INFORMATION: I. Background Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the Federal Motor Carrier Safety Regulations for a 2-year period if it finds ``such exemption would likely achieve a level of safety that is equivalent to or greater than the level that would be achieved absent such exemption.'' The statute also allows the Agency to renew exemptions at the end of the 2-year period. The 41 individuals listed in this notice have recently requested such an exemption from the diabetes prohibition in 49 CFR 391.41(b)(3), which applies to drivers of CMVs in interstate commerce. Accordingly, the Agency will evaluate the qualifications of each applicant to determine whether granting the exemption will achieve the required level of safety mandated by statute. II. Qualifications of Applicants Donald Austin Mr. Austin, 63, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Austin understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Austin meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Estil L. Baker, Jr. Mr. Baker, 58, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Baker understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Baker meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Thomas M. Bard Mr. Bard, 41, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bard understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bard meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Mark W. Birch Mr. Birch, 46, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Birch understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Birch meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Texas. Richard Bollhardt Mr. Bollhardt, 56, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Bollhardt understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Bollhardt meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Bryan R. Breaw Mr. Breaw, 48, has had ITDM since 1987. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in [[Page 96170]] the last 5 years. His endocrinologist certifies that Mr. Breaw understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Breaw meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Trini L. Brisson Mr. Brisson, 48, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Brisson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Brisson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Michigan. Keith M. Carpenter Mr. Carpenter, 51, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carpenter understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carpenter meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Pennsylvania. Alan W. Carstensen Mr. Carstensen, 72, has had ITDM since 2014. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Carstensen understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Carstensen meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Minnesota. Russell L. Clapp Mr. Clapp, 56, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Clapp understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Clapp meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Maine. Allan J. Clune Mr. Clune, 73, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Clune understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Clune meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Ryan F. Curtis Mr. Curtis, 27, has had ITDM since 1996. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Curtis understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Curtis meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from New Jersey. Jeffrey S. Daniels Mr. Daniels, 50, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Daniels understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Daniels meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class C CDL from Iowa. Andrew M.M. Danner Mr. Danner, 21, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Danner understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Danner meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Virginia. [[Page 96171]] George P. Diedrich, Jr. Mr. Diedrich, 74, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Diedrich understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Diedrich meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. Wilson E. Donnell Mr. Donnell, 63, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Donnell understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Donnell meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Maine. Michael W. Erick Mr. Erick, 62, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Erick understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Erick meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Connecticut. Eric Fedor Mr. Fedor, 56, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Fedor understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Fedor meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Juanita C. Gaines Ms. Gaines, 54, has had ITDM since 2002. Her endocrinologist examined her in 2016 and certified that she has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. Her endocrinologist certifies that Ms. Gaines understands diabetes management and monitoring has stable control of her diabetes using insulin, and is able to drive a CMV safely. Ms. Gaines meets the requirements of the vision standard at 49 CFR 391.41(b)(10). Her optometrist examined her in 2016 and certified that she does not have diabetic retinopathy. She holds a Class B CDL from Texas. Buckley E. Grant Mr. Grant, 44, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Grant understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Grant meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Kansas. Connor J. Grossaint Mr. Grossaint, 23, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Grossaint understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Grossaint meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Utah. Brian A. Hagenhoff Mr. Hagenhoff, 44, has had ITDM since 1989. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hagenhoff understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Hagenhoff meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Missouri. Jeffrey D.S. Hosman Mr. Hosman, 23, has had ITDM since 1998. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Hosman understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV [[Page 96172]] safely. Mr. Hosman meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from Arkansas. Terry P. Kelly Mr. Kelly, 50, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kelly understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kelly meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class D CDL from Kentucky. David M. Kerr Mr. Kerr, 58, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kerr understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kerr meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Pennsylvania. Michael P. Kruimer Mr. Kruimer, 62, has had ITDM since 2012. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Kruimer understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Kruimer meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from New Jersey. Salvatore Longo Mr. Longo, 45, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Longo understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Longo meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Illinois. Alan Mills Mr. Mills, 62, has had ITDM since 2011. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Mills understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Mills meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Oregon. John R. Paulus Mr. Paulus, 69, has had ITDM since 1974. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Paulus understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Paulus meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. Bruce D. Peterson Mr. Peterson, 65, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Peterson understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Peterson meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds a Class A CDL from Wisconsin. Nicholas J. Powden Mr. Powden, 30, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Powden understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Powden meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Vermont. Dennis A. Roisum Mr. Roisum, 59, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or [[Page 96173]] more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Roisum understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Roisum meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative diabetic retinopathy. He holds an operator's license from Wisconsin. Jeffrey P. Roskopf Mr. Roskopf, 61, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Roskopf understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Roskopf meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Wisconsin. David M. Ryea Mr. Ryea, 36, has had ITDM since 2001. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Ryea understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Ryea meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds an operator's license from Connecticut. Edward G. Smith, Jr. Mr. Smith, 58, has had ITDM since 2013. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Smith understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Smith meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from North Dakota. Ralph H. Talmadge Mr. Talmadge, 71, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Talmadge understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Talmadge meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class B CDL from New Jersey. Jerry R. Thomason Mr. Thomason, 57, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Thomason understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Thomason meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Georgia. Melvin E. Turner Mr. Turner, 62, has had ITDM since 2015. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Turner understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Turner meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Tennessee. Lash L. Walker Mr. Walker, 64, has had ITDM since 2006. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Walker understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Walker meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in 2016 and certified that he has stable nonproliferative and stable proliferative diabetic retinopathy. He holds an operator's license from Tennessee. Donald E. Walstrom Mr. Walstrom, 57, has had ITDM since 2016. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Walstrom understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Walstrom meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Iowa. [[Page 96174]] Ronald A. Williams Mr. Williams, 66, has had ITDM since 2010. His endocrinologist examined him in 2016 and certified that he has had no severe hypoglycemic reactions resulting in loss of consciousness, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the last 5 years. His endocrinologist certifies that Mr. Williams understands diabetes management and monitoring, has stable control of his diabetes using insulin, and is able to drive a CMV safely. Mr. Williams meets the requirements of the vision standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2016 and certified that he does not have diabetic retinopathy. He holds a Class A CDL from Oregon. III. Request for Comments In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests public comment from all interested persons on the exemption petitions described in this notice. We will consider all comments received before the close of business on the closing date indicated in the date section of the notice. FMCSA notes that section 4129 of the Safe, Accountable, Flexible and Efficient Transportation Equity Act: A Legacy for Users requires the Secretary to revise its diabetes exemption program established on September 3, 2003 (68 FR 52441) \1\. The revision must provide for individual assessment of drivers with diabetes mellitus, and be consistent with the criteria described in section 4018 of the Transportation Equity Act for the 21st Century (49 U.S.C. 31305). --------------------------------------------------------------------------- \1\ Section 4129(a) refers to the 2003 notice as a ``final rule.'' However, the 2003 notice did not issue a ``final rule'' but did establish the procedures and standards for issuing exemptions for drivers with ITDM. --------------------------------------------------------------------------- Section 4129 requires: (1) Elimination of the requirement for 3 years of experience operating CMVs while being treated with insulin; and (2) establishment of a specified minimum period of insulin use to demonstrate stable control of diabetes before being allowed to operate a CMV. In response to section 4129, FMCSA made immediate revisions to the diabetes exemption program established by the September 3, 2003 notice. FMCSA discontinued use of the 3-year driving experience and fulfilled the requirements of section 4129 while continuing to ensure that operation of CMVs by drivers with ITDM will achieve the requisite level of safety required of all exemptions granted under 49 U.S.C.. 31136 (e). Section 4129(d) also directed FMCSA to ensure that drivers of CMVs with ITDM are not held to a higher standard than other drivers, with the exception of limited operating, monitoring and medical requirements that are deemed medically necessary. The FMCSA concluded that all of the operating, monitoring and medical requirements set out in the September 3, 2003 notice, except as modified, were in compliance with section 4129(d). Therefore, all of the requirements set out in the September 3, 2003 notice, except as modified by the notice in the Federal Register on November 8, 2005 (70 FR 67777), remain in effect. IV. Submitting Comments You may submit your comments and material online or by fax, mail, or hand delivery, but please use only one of these means. FMCSA recommends that you include your name and a mailing address, an email address, or a phone number in the body of your document so that FMCSA can contact you if there are questions regarding your submission. To submit your comment online, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0381 and click the search button. When the new screen appears, click on the blue ``Comment Now!'' button on the right hand side of the page. On the new page, enter information required including the specific section of this document to which each comment applies, and provide a reason for each suggestion or recommendation. If you submit your comments by mail or hand delivery, submit them in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for copying and electronic filing. If you submit comments by mail and would like to know that they reached the facility, please enclose a stamped, self-addressed postcard or envelope. We will consider all comments and material received during the comment period. FMCSA may issue a final determination at any time after the close of the comment period. V. Viewing Comments and Documents To view comments, as well as any documents mentioned in this preamble, go to http://www.regulations.gov and in the search box insert the docket number FMCSA-2016-0381 and click ``Search.'' Next, click ``Open Docket Folder'' and you will find all documents and comments related to this notice. Issued on: December 19, 2016. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2016-31546 Filed 12-28-16; 8:45 am] BILLING CODE 4910-EX-P
![96168 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
71610; 69 FR 71098; 71 FR 32183; 71 FR 71 FR 63379; 72 FR 1050; 73 FR 42403; IV. Preemption
41310; 71 FR 63379; 72 FR 1050; 72 FR 73 FR 78422; 75 FR 38602; 75 FR 54958; During the period the exemption is in
1054; 73 FR 75806; 73 FR 78421; 75 FR 75 FR 96737; 75 FR 70078; 75 FR 72863; effect, no State shall enforce any law or
79079; 77 FR 76166; 79 FR 73687): 75 FR 77492; 75 FR 79079; 76 FR 1499; regulation that conflicts with this
David S. Brumfield (KY) 76 FR 2190; 76 FR 5425; 77 FR 60008; exemption with respect to a person
Arthur A. Sappington (IN) 77 FR 68202; 77 FR 71671; 77 FR 74733; operating under the exemption.
David W. Skillman (WA) 78 FR 800; 80 FR 603):
William H. Smith (AL) Gary Alvarez (MA) VI. Conclusion
Edward C. Williams (AL) Donald G. Brock, Jr. (NC) Based upon its evaluation of the 128
The drivers were included on the Leon C. Flynn (TX) exemption applications, FMCSA renews
following docket: Docket No. FMCSA– Brett K. Hasty (GA) the exemptions of the aforementioned
2000–7363; FMCSA–2002–12294; Garry Layton (TX) drivers from the vision requirement in
FMCSA–2006–24783; FMCSA–2006– Jimmy R. Mauldin (OK) 49 CFR 391.41(b)(10), subject to the
26006. Their exemptions are effective as Patrick J. McMillen (WI) requirements cited above (49 CFR
of January 13, 2017, and will expire on Anthony Miller (OH) 391.64(b)). In accordance with 49 U.S.C.
January 13, 2019. Rocky Moorhead (NM) 31136(e) and 31315, each exemption
As of January 14, 2017, and in Gary L. Nicholas (MI) will be valid for two years unless
accordance with 49 U.S.C. 31136(e) and Jose M. Saurez (TX) revoked earlier by FMCSA.
31315, the following 10 individuals Lynn R. Schraeder (IA) Issued on: December 19, 2016.
have satisfied the conditions for Ranjodh Singh (CA) Larry W. Minor,
obtaining a renewed exemption from the Myron A. Smith (MN)
Associate Administrator for Policy.
vision requirements (69 FR 64806; 70 Ricky Watts (FL)
[FR Doc. 2016–31557 Filed 12–28–16; 8:45 am]
FR 2705; 72 FR 1056; 73 FR 76439; 75 Olen L. Williams, Jr. (TN)
Richard L. Zacher (OR) BILLING CODE 4910–EX–P
FR 65057; 75 FR 79081; 75 FR 79084;
77 FR 75496; 79 FR 74169): The drivers were included on the
Charles L. Alsager, Jr. (IA) following docket: Docket No. FMCSA– DEPARTMENT OF TRANSPORTATION
Ross E. Burroughs (NJ) 2004–17195; FMCSA–2006–26066;
Christopher L. Depuy (OH) FMCSA–2010–0201; FMCSA–2010– Federal Motor Carrier Safety
John B. Etheridge (GA) 0287; FMCSA–2010–0354; FMCSA– Administration
Larry J. Folkerts (IA) 2010–0385; FMCSA–2012–0279. Their
exemptions are effective as of January [Docket No. FMCSA–2016–0381]
Paul W. Hunter (AL)
Ray P. Lenz (IA) 31, 2017, and will expire on January 31, Qualification of Drivers; Exemption
Francis M. McMullin (PA) 2019. Applications; Diabetes Mellitus
Norman Mullins (OH) Conditions and Requirements
David J. Triplett (KY) AGENCY: Federal Motor Carrier Safety
The exemptions are extended subject Administration (FMCSA), Department
The drivers were included on the to the following conditions: (1) Each of Transportation.
following docket: Docket No. FMCSA– driver must undergo an annual physical ACTION: Notice of applications for
2004–19477; FMCSA–2010–0327. Their examination (a) by an ophthalmologist
exemptions are effective as of January exemptions; request for comments.
or optometrist who attests that the
14, 2017, and will expire on January 14, vision in the better eye continues to SUMMARY: FMCSA announces receipt of
2019. meet the requirements in 49 CFR applications from 41 individuals for
As of January 17, 2017, and in 391.41(b)(10), and (b) by a certified exemption from the prohibition against
accordance with 49 U.S.C. 31136(e) and Medical Examiner, as defined by 49 CFR persons with insulin-treated diabetes
31315, the following 5 individuals have 390.5, who attests that the driver is mellitus (ITDM) operating commercial
satisfied the conditions for obtaining a otherwise physically qualified under 49 motor vehicles (CMVs) in interstate
renewed exemption from the vision CFR 391.41; (2) each driver must commerce. If granted, the exemptions
requirements (67 FR 68719; 68 FR 2629; provide a copy of the ophthalmologist’s would enable these individuals with
69 FR 71100; 72 FR 1053; 73 FR 76440; or optometrist’s report to the Medical ITDM to operate CMVs in interstate
75 FR 80887; 77 FR 76167; 79 FR Examiner at the time of the annual commerce.
74168): medical examination; and (3) each DATES: Comments must be received on
Howard F. Breitkreutz (MN) driver must provide a copy of the or before January 30, 2017.
John E. Evenson (WI) annual medical certification to the ADDRESSES: You may submit comments
Craig M. Landry (LA) employer for retention in the driver’s bearing the Federal Docket Management
Kenneth E. Vigue, Jr. (WA) qualification file and retains a copy of System (FDMS) Docket No. FMCSA–
Richard A. Winslow (MN) the certification on his/her person while 2016–0381 using any of the following
The drivers were included on the driving for presentation to a duly methods:
following docket: Docket No. FMCSA– authorized Federal, State, or local • Federal eRulemaking Portal: Go to
2002–12844. Their exemptions are enforcement official. The exemption http://www.regulations.gov. Follow the
effective as of January 17, 2017, and will will be rescinded if: (1) The person fails
asabaliauskas on DSK3SPTVN1PROD with NOTICES
on-line instructions for submitting
expire on January 17, 2019. to comply with the terms and comments.
As of January 31, 2017, and in conditions of the exemption; (2) the • Mail: Docket Management Facility;
accordance with 49 U.S.C. 31136(e) and exemption has resulted in a lower level U.S. Department of Transportation, 1200
31315, the following 17 individuals of safety than was maintained before it New Jersey Avenue SE., West Building
have satisfied the conditions for was granted; or (3) continuation of the Ground Floor, Room W12–140,
obtaining a renewed exemption from the exemption would not be consistent with Washington, DC 20590–0001.
vision requirements (69 FR 17263; 69 the goals and objectives of 49 U.S.C. • Hand Delivery: West Building
FR 314477; 70 FR 44946; 71 FR 43557; 31136(e) and 31315. Ground Floor, Room W12–140, 1200
VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 PO 00000 Frm 00213 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1](https://thefederalregister.org/doc/81_FR_96418/page/1.svg)
![96174 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices
Ronald A. Williams required of all exemptions granted Issued on: December 19, 2016.
under 49 U.S.C.. 31136 (e). Larry W. Minor,
Mr. Williams, 66, has had ITDM since
Section 4129(d) also directed FMCSA Associate Administrator for Policy.
2010. His endocrinologist examined him
in 2016 and certified that he has had no to ensure that drivers of CMVs with [FR Doc. 2016–31546 Filed 12–28–16; 8:45 am]
severe hypoglycemic reactions resulting ITDM are not held to a higher standard BILLING CODE 4910–EX–P
in loss of consciousness, requiring the than other drivers, with the exception of
assistance of another person, or limited operating, monitoring and
resulting in impaired cognitive function medical requirements that are deemed DEPARTMENT OF TRANSPORTATION
that occurred without warning in the medically necessary.
Federal Motor Carrier Safety
past 12 months and no recurrent (2 or The FMCSA concluded that all of the
Administration
more) severe hypoglycemic episodes in operating, monitoring and medical
the last 5 years. His endocrinologist requirements set out in the September 3, [Docket No. FMCSA–2014–0216]
certifies that Mr. Williams understands 2003 notice, except as modified, were in
diabetes management and monitoring, compliance with section 4129(d). Qualification of Drivers; Exemption
has stable control of his diabetes using Therefore, all of the requirements set Applications; Epilepsy and Seizure
insulin, and is able to drive a CMV out in the September 3, 2003 notice, Disorders
safely. Mr. Williams meets the except as modified by the notice in the AGENCY: Federal Motor Carrier Safety
requirements of the vision standard at Federal Register on November 8, 2005 Administration (FMCSA), DOT.
49 CFR 391.41(b)(10). His optometrist (70 FR 67777), remain in effect.
ACTION: Notice of renewal of
examined him in 2016 and certified that exemptions; request for comments.
IV. Submitting Comments
he does not have diabetic retinopathy.
He holds a Class A CDL from Oregon. You may submit your comments and SUMMARY: FMCSA announces its
III. Request for Comments material online or by fax, mail, or hand decision to renew exemptions of three
delivery, but please use only one of individuals from the requirement in the
In accordance with 49 U.S.C. 31136(e) these means. FMCSA recommends that Federal Motor Carrier Safety
and 31315, FMCSA requests public you include your name and a mailing Regulations (FMCSRs) that interstate
comment from all interested persons on address, an email address, or a phone commercial motor vehicle (CMV)
the exemption petitions described in number in the body of your document drivers have ‘‘no established medical
this notice. We will consider all so that FMCSA can contact you if there history or clinical diagnosis of epilepsy
comments received before the close of are questions regarding your or any other condition which is likely
business on the closing date indicated submission. to cause loss of consciousness or any
in the date section of the notice. To submit your comment online, go to loss of ability to control a CMV.’’ The
FMCSA notes that section 4129 of the http://www.regulations.gov and in the exemptions enable these individuals
Safe, Accountable, Flexible and search box insert the docket number who have had one or more seizures and
Efficient Transportation Equity Act: A FMCSA–2016–0381 and click the search are taking anti-seizure medication to
Legacy for Users requires the Secretary button. When the new screen appears, continue to operate CMVs in interstate
to revise its diabetes exemption program click on the blue ‘‘Comment Now!’’ commerce.
established on September 3, 2003 (68 FR button on the right hand side of the DATES: The renewed exemptions were
52441) 1. The revision must provide for page. On the new page, enter effective on November 4, 2016. The
individual assessment of drivers with information required including the renewed exemptions will expire on
diabetes mellitus, and be consistent specific section of this document to November 4, 2018. Comments must be
with the criteria described in section which each comment applies, and received on or before January 30, 2017.
4018 of the Transportation Equity Act provide a reason for each suggestion or FOR FURTHER INFORMATION CONTACT: Ms.
for the 21st Century (49 U.S.C. 31305). recommendation. If you submit your Christine A. Hydock, Chief, Medical
Section 4129 requires: (1) Elimination comments by mail or hand delivery, Programs Division, 202–366–4001,
of the requirement for 3 years of submit them in an unbound format, no fmcsamedical@dot.gov, FMCSA,
experience operating CMVs while being larger than 81⁄2 by 11 inches, suitable for Department of Transportation, 1200
treated with insulin; and (2) copying and electronic filing. If you New Jersey Avenue SE., Room W64–
establishment of a specified minimum submit comments by mail and would 224, Washington, DC 20590–0001.
period of insulin use to demonstrate like to know that they reached the Office hours are from 8:30 a.m. to 5
stable control of diabetes before being facility, please enclose a stamped, self- p.m., e.t., Monday through Friday,
allowed to operate a CMV. addressed postcard or envelope. except Federal holidays. If you have
In response to section 4129, FMCSA We will consider all comments and questions regarding viewing or
made immediate revisions to the material received during the comment submitting material to the docket,
diabetes exemption program established period. FMCSA may issue a final contact Docket Services, telephone (202)
by the September 3, 2003 notice. determination at any time after the close 366–9826.
FMCSA discontinued use of the 3-year of the comment period. ADDRESSES: You may submit comments
driving experience and fulfilled the bearing the Federal Docket Management
requirements of section 4129 while V. Viewing Comments and Documents
System (FDMS) Docket No. FMCSA–
asabaliauskas on DSK3SPTVN1PROD with NOTICES
continuing to ensure that operation of To view comments, as well as any 2014–0216 using any of the following
CMVs by drivers with ITDM will documents mentioned in this preamble, methods:
achieve the requisite level of safety go to http://www.regulations.gov and in • Federal eRulemaking Portal: Go to
the search box insert the docket number http://www.regulations.gov. Follow the
1 Section 4129(a) refers to the 2003 notice as a
FMCSA–2016–0381 and click ‘‘Search.’’ online instructions for submitting
‘‘final rule.’’ However, the 2003 notice did not issue
a ‘‘final rule’’ but did establish the procedures and
Next, click ‘‘Open Docket Folder’’ and comments.
standards for issuing exemptions for drivers with you will find all documents and • Mail: Docket Management Facility;
ITDM. comments related to this notice. U.S. Department of Transportation, 1200
VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 PO 00000 Frm 00219 Fmt 4703 Sfmt 4703 E:\FR\FM\29DEN1.SGM 29DEN1](https://thefederalregister.org/doc/81_FR_96418/page/7.svg)
Document Created: 2016-12-29 01:58:48
Document Modified: 2016-12-29 01:58:48
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of applications for exemptions; request for comments. | |
| Dates | Comments must be received on or before January 30, 2017. | |
| Contact | Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366-4001, [email protected], FMCSA, Department of Transportation, 1200 New Jersey Avenue SE., Room W64-113, Washington, DC 20590-0001. Office hours are 8:30 a.m. to 5 p.m., e.t., Monday through Friday, except Federal holidays. | |
| FR Citation | 81 FR 96168 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR